"The right diagnosis can be life changing- The Rowe Neurology Institute provides caring individualized comprehensive diagnosis and treatment for patients with neurological diseases. We also provide patients with an opportunity to participate in FDA supervised clinical trials in MS, Alzheimer's Disease, Headache, and Sleep Disorders, -disorders for which no cause has been found and no cure is known. We are an independent, free standing Institute, and provide cost effective care for patients with high deductibles. We are out of network, and are independent from all hospital systems and insurance plans, but can work with all of them."

During the past decade, Rowe Neurology Institute RNI - Lenexa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rowe Neurology Institute RNI - Lenexa" are "Obstructive Sleep Apnea" (2 trials) and "Narcolepsy" (1 trials). Many other conditions were trialed in "Rowe Neurology Institute RNI - Lenexa" in a lesser frequency.

Most popular intervention types in "Rowe Neurology Institute RNI - Lenexa" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "JZP-110" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rowe Neurology Institute RNI - Lenexa" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rowe Neurology Institute RNI - Lenexa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rowe Neurology Institute RNI - Lenexa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rowe Neurology Institute RNI - Lenexa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".